Dea No. 1680 en es it fr

Dea No. 1680 Brand names, Dea No. 1680 Analogs

Dea No. 1680 Brand Names Mixture

  • No information avaliable

Dea No. 1680 Chemical_Formula


Dea No. 1680 RX_link

Dea No. 1680 fda sheet

Dea_No._1680 FDA

Dea No. 1680 msds (material safety sheet)

Dea_No._1680 MSDS

Dea No. 1680 Synthesis Reference

L. Lafon, U.S. pat. 4,927,855, (1990)

Dea No. 1680 Molecular Weight

273.351 g/mol

Dea No. 1680 Melting Point

164-166 oC

Dea No. 1680 H2O Solubility

Slightly soluble

Dea No. 1680 State


Dea No. 1680 LogP


Dea No. 1680 Dosage Forms


Dea No. 1680 Indication

To improve wakefulness in patients with excessive daytime sleepiness (EDS) associated with narcolepsy.

Dea No. 1680 Pharmacology

Modafinil is a stimulant drug marketed as a 'wakefulness promoting agent' and is one of the stimulants used in the treatment of narcolepsy. Narcolepsy is caused by dysfunction of a family of wakefulness-promoting and sleep-suppressing peptides, the orexins, whose neurons are activated by modafinil. The prexin neuron activation is associated with psychoactivation and euphoria. Modafinil is not indicated for complaints of lack of energy or fatigue; but it appears to be very helpful for some patients. Also, it has been used in the treatment of hypersomnia, a disorder in which patients lack the capacity for meaningful sleep and may require ten or more hours per day. Recent studies have have found that modafinil may help recovering cocaine addicts fight their addiction.

Dea No. 1680 Absorption

Rapid following oral administration.

Dea No. 1680 side effects and Toxicity

No information avaliable

Dea No. 1680 Patient Information

Dea No. 1680 Organisms Affected

Humans and other mammals